Seeking Alpha

More on Stryker (SYK): Q4 beats on both EPS and revenue estimates on a 4.2% Y/Y increase in...

More on Stryker (SYK): Q4 beats on both EPS and revenue estimates on a 4.2% Y/Y increase in sales. Net profit fell 33% Y/Y on hefty charges related to a product recall, while sales continued to strengthen. Neuro-technology and Spine net sales increased 9.7% Y/Y, with its reconstructive segment growing by 6.7% over the same period.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|